15/05/2024  11:39:40 Chg. +2.80 Volume Bid11:39:51 Demandez à11:39:51 Capitalisation boursière Dividende Y. Rapport P/E
248.00CHF +1.14% 3,770
Chiffrre d'affaires: 932,268.10
247.80Bid taille: 117 248.00Ask la taille: 87 210.08 Mrd.CHF 3.83% 17.22

Description de l'entreprise

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
 

Conseil d'administration & Conseil de surveillance

PDG
Dr. Thomas Schinecker
Conseil d'administration
Dr. Alan Hippe, Cristina A. Wilbur, Teresa Graham, Matt Sause , Claudia Bockstiegel, Prof. Dr. Hans Clevers, Dr. Levi Garraway, Silke Hornstein, Dr. Aviv Regev, Dr. James H. Sabry, Barbara Schadler
Conseil de surveillance
André Hoffmann, Anita Hauser, Bernard Poussot, Dr. Claudia Süssmuth Dyckerhoff, Dr. Patrick Frost, Dr. Severin Schwan, Prof. Dr. Richard Lifton, Dr. Mark Schneider, Dr. Jemilah Mahmood, Prof. Dr. Akiko Iwasaki, Dr. Joorg Duschmale
 

Données de l'entreprise

Nom: Roche Holding
Adresse: Grenzacherstraße 124,CH-4070 Basel
Téléphone: +41-61-688-1111
Fax: -
Courriel: basel.webmaster@roche.com
Internet: www.roche.com
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 88.00%
IPO date: 03/04/1995

Relations avec les investisseurs

Nom: Bruno Eschli
Téléphone IR: +41 (61) 687 5284
IR-Fax: +41 (61) 691 0014
E-mail IR: investor.relations@roche.com

Principaux actionnaires

Aktionärsgruppe der Familien Hoffmann und Oeri-Hoffmann
 
67.50%
Freefloat
 
24.92%
Maja Oeri
 
7.58%